D-1254-2020 Class I Terminated
FDA drug recall D-1254-2020 was initiated by Avet Pharmaceuticals, Inc. on Mar 23, 2020 and is designated Class I. Reason for recall: Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules. The recall status is terminated (terminated Aug 23, 2022). Affected quantity: 17,524 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 15, 2020
- Initiation Date
- Mar 23, 2020
- Termination Date
- Aug 23, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,524 bottles
Product description
Tetracycline HCL Capsules, USP, 500 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-018-01
Reason for recall
Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Distribution pattern
Distributed Nationwide in the US
Code information
Lot #s: G190609, G190610, G190611, Exp Jun 2022: L191027, L191028, Exp Nov 2022: K190953, K190952, Exp Oct 2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1254-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026